Tvardi Therapeutics, Inc. Balance Sheet
TVRD|11 years of annual SEC 10-K data (FY2014-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 11 fiscal years. All figures from audited SEC 10-K filings.
Tvardi Therapeutics, Inc. had $44M in total assets and $57M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37.9M | $51.8M | $63.7M | $13.5M | $31.7M | $18.3M | $15.1M | $9.4M | $52.7M | $12.4M | $1.1M |
| Accounts Receivable | $407.0K | $2.8M | - | - | - | - | - | - | - | - | - |
| Inventory | $900.0K | $2.8M | $2.4M | $2.6M | - | - | - | - | - | - | - |
| Current Assets | $43.8M | $116.2M | $168.9M | $173.3M | $195.1M | $165.7M | $168.1M | $95.1M | $61.4M | $108.9M | $53.1M |
| PP&E (Net) | - | $3.3M | $426.0K | $631.0K | $840.0K | $700.0K | $880.0K | $1.2M | $1.6M | $1.3M | $2.1M |
| Total Assets | $43.8M | $125.8M | $182.2M | $247.1M | $271.2M | $233.0M | $190.8M | $97.0M | $63.8M | $110.9M | $55.9M |
| Current Liabilities | $4.0M | $25.6M | $23.5M | $17.6M | $18.5M | $42.9M | $40.4M | $8.5M | $11.5M | $5.3M | $3.4M |
| Shareholders' Equity | $57.1M | $227.5M | $249.0M | $186.7M | $133.6M | $86.8M | $50.7M | $105.0M | $51.7M | -$54.1M | -$58.1M |